Biography

Dr. Maria G. Segura is a board-certified Pediatric Infectious Diseases physician with a strong foundation in general pediatrics and a passion for preventive care. Her clinical interests include general pediatrics, pediatric infectious diseases, and the promotion of preventive health through vaccines.

Dr. Segura’s research focuses on Group A Streptococcus and the management of infections in immunocompromised populations, with the goal of improving outcomes for medically vulnerable children. She brings a thoughtful, evidence-based approach to patient care and is committed to advancing pediatric infectious disease research and practice.

Education

Medical Doctor
Universidad de Carabobo, Valencia, Venezuela
Pediatric Residency
UTHealth Houston
Pediatric Infectious Diseases Fellowship
UTHealth Houston

Areas of Interest

Clinical Interests

General Pediatrics, Pediatric Infectious Diseases, Musculoskeletal Infections, Preventive Care and Vaccines

Research Interests

Group A Streptococcus and the immunocompromised population.

Publications

Aboulhosn, A., Sanson, M. A., Vega, L. A., Segura, M. G., Summer, L. M., Joseph, M., McNeil, J. C., & Flores, A. R.: Influence of the COVID-19 Pandemic on Antimicrobial Resistance Patterns in Pediatric Group A Streptococcus Infections in Houston, TX. 13th Annual Pediatric Research Symposium. 05/2024.

Aboulhosn, A., Sanson, M. A., Vega, L. A., Segura, M. G., Summer, L. M., Joseph, M., McNeil, J. C., & Flores, A. R.: Increases in group A streptococcal infections in the pediatric population in Houston, TX, 2022. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 04/2023

Hennessy, M. Wahba, A. Felix, K. Cabrera, M. Segura, M. Kundra, V. Ravoori, M. Stewart, J. Kleinerman, E. Jensen, V. Gopalakrishnan, V. Pena, R. Quach, P. Kim, G. Kivimäe, S. Madakamutil, L. Overwijk, W. Zalevsky, J. Gordon, N.: Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma. International Journal of Cancer. 05/2020.